$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Dietary Intake of 17α-Ethinylestradiol Promotes HCC Progression in Humanized Male Mice Expressing Sex Hormone-Binding Globulin 원문보기

International journal of molecular sciences, v.22 no.22, 2021년, pp.12557 -   

Lee, Sang R. ,  Jeong, Su Hee ,  Heo, Jun H. ,  Jo, Seong Lae ,  Ko, Je-Won ,  Kwun, Hyo-Jung ,  Hong, Eui-Ju

Abstract AI-Helper 아이콘AI-Helper

Hepatocellular carcinoma (HCC) is a male-oriented malignancy; its progression is affected by sex hormones. 17α-ethinylestradiol (EE2) is a synthetic estrogen widely used as an oral contraceptive; however, it is unknown whether EE2 regulates sex hormone action in HCC. We investigated whether EE...

Keyword

참고문헌 (56)

  1. 1. Naugler W.E. Sakurai T. Kim S. Maeda S. Kim K. Elsharkawy A.M. Karin M. Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production Science 2007 317 121 124 10.1126/science.1140485 17615358 

  2. 2. Zhang H. Li X. Yang Y. Zhang Y. Wang H.-Y. Zheng X.S. Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma Hepatology 2018 67 2271 2286 10.1002/hep.29715 29220539 

  3. 3. Keng V.W. Largaespada D.A. Villanueva A. Why men are at higher risk for hepatocellular carcinoma? J. Hepatol. 2012 57 453 454 10.1016/j.jhep.2012.03.004 22425699 

  4. 4. Hammond G.L. Plasma steroid-binding proteins: Primary gatekeepers of steroid hormone action J. Endocrinol. 2016 230 R13 R25 10.1530/JOE-16-0070 27113851 

  5. 5. Hammond G.L. Diverse Roles for Sex Hormone-Binding Globulin in Reproduction Biol. Reprod. 2011 85 431 441 10.1095/biolreprod.111.092593 21613632 

  6. 6. Laurent M. Hammond G. Blokland M. Jardi F. Antonio L. Dubois V. Khalil R. Sterk S.S. Gielen E. Decallonne B. Sex hormone-binding globulin regulation of androgen bioactivity in vivo: Validation of the free hormone hypothesis Sci. Rep. 2016 6 35539 10.1038/srep35539 27748448 

  7. 7. Hong E.-J. Sahu B. Janne O.A. Hammond G. Cytoplasmic Accumulation of Incompletely Glycosylated SHBG Enhances Androgen Action in Proximal Tubule Epithelial Cells Mol. Endocrinol. 2011 25 269 281 10.1210/me.2010-0483 21193555 

  8. 8. Lee S.R. Lee Y.H. Yang H. Lee H.W. Lee G.-S. An B.-S. Jeung E.-B. Park B.-K. Hong E.-J. Sex hormone-binding globulin suppresses NAFLD-triggered hepatocarcinogenesis after menopause Carcinogenesis 2019 40 1031 1041 10.1093/carcin/bgz107 31168625 

  9. 9. Endrikat J. Muller U. Dusterberg B. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance Contraception 1997 55 131 137 9115000 

  10. 10. Campen D. Maronpot R. Lucier G. Dose-response relationships in promotion of rat hepatocarcinogenesis by 17α-ethinylestradiol J. Toxicol. Environ. Health Part A Curr. Issues 1990 29 257 268 10.1080/15287399009531389 

  11. 11. Yager J.D. Campbell H.A. Longnecker D.S. Roebuck B.D. Benoit M.C. Enhancement of hepatocarcinogenesis in female rats by ethinyl estradiol and mestranol but not estradiol Cancer Res. 1984 44 3862 3869 6744303 

  12. 12. Ferrara B.E. Rutland E.D. Liver tumor in long-term user of oral contraceptives Postgrad. Med. 1988 84 107 109 10.1080/00325481.1988.11700466 2847128 

  13. 13. McGlynn K.A. Sahasrabuddhe V.V. Campbell P.T. Graubard B.I. Chen J. Schwartz L.M. Petrick J.L. Alavanja M.C. Andreotti G. Boggs D.A. Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: Results from the Liver Cancer Pooling Project Br. J. Cancer 2015 112 1266 1272 10.1038/bjc.2015.58 25742475 

  14. 14. Langeveld J.W. Lycklama A.A.B. Nijeholt A. Jonas U. Oestrogen in the treatment of prostatic carcinoma. What is the safe and effective dose of ethinyloestradiol? Br. J. Urol. 1989 63 76 79 10.1111/j.1464-410X.1989.tb05128.x 2920266 

  15. 15. Hayashi T. Sekii Y. Katayama K. Kamoto A. Kakuta Y. Mori N. Itatani H. Yoshioka T. The efficacy of ethinylestradiol for castration-resistant prostate cancer Nihon Hinyokika Gakkai Zasshi 2014 105 37 42 24908814 

  16. 16. Izumi K. Kadono Y. Shima T. Konaka H. Mizokami A. Koh E. Namiki M. Ethinylestradiol improves prostate-specific antigen levels in pretreated castration-resistant prostate cancer patients Anticancer Res. 2010 30 5201 5205 21187513 

  17. 17. Hasegawa Y. Tomita M. Asano K. Hasegawa N. Ikemoto I. Onodera S. Ohishi Y. Ishikawa T. Primary, nonviral, hepatocellular carcinoma in patients with prostate cancer treated by hormone therapy: 2 case reports Nihon Hinyokika Gakkai Zasshi 2005 96 503 506 15948411 

  18. 18. Refolo M.G. Messa C. Guerra V. Carr B.I. D’Alessandro R. Inflammatory Mechanisms of HCC Development Cancers 2020 12 641 10.3390/cancers12030641 32164265 

  19. 19. Wallach D. Kovalenko A. Keeping inflammation at bay eLife 2014 3 e02583 10.7554/eLife.02583 24668174 

  20. 20. Koyama Y. Brenner D.A. Liver inflammation and fibrosis J. Clin. Investig. 2017 127 55 64 10.1172/JCI88881 28045404 

  21. 21. Bohm F. Kohler U.A. Speicher T. Werner S. Regulation of liver regeneration by growth factors and cytokines EMBO Mol. Med. 2010 2 294 305 10.1002/emmm.201000085 20652897 

  22. 22. Giannitrapani L. Soresi M. La Spada E. Cervello M. D’Alessandro N. Montalto G. Sex Hormones and Risk of Liver Tumor Ann. N. Y. Acad. Sci. 2006 1089 228 236 10.1196/annals.1386.044 17261770 

  23. 23. Tanaka K. Sakai H. Hashizume M. Hirohata T. Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients Cancer Res. 2000 60 5106 5110 11016636 

  24. 24. Stanczyk F.Z. Archer D.F. Bhavnani B.R. Ethinyl estradiol and 17beta-estradiol in combined oral contraceptives: Pharmacokinetics, pharmacodynamics and risk assessment Contraception 2013 87 706 727 10.1016/j.contraception.2012.12.011 23375353 

  25. 25. Blair R.M. Fang H. Branham W.S. Hass B.S. Dial S.L. Moland C.L. Tong W. Shi L. Perkins R. Sheehan D.M. The Estrogen Receptor Relative Binding Affinities of 188 Natural and Xenochemicals: Structural Diversity of Ligands Toxicol. Sci. 2000 54 138 153 10.1093/toxsci/54.1.138 10746941 

  26. 26. Hee L. Kettner L.O. Vejtorp M. Continuous use of oral contraceptives: An overview of effects and side-effects Acta Obstet. Gynecol. Scand. 2012 92 125 136 10.1111/aogs.12036 23083413 

  27. 27. Janne M. Hogeveen K.N. Deol H.K. Hammond G.L. Expression and regulation of human sex hormone-binding globulin transgenes in mice during development Endocrinology 1999 140 4166 4174 10465289 

  28. 28. Lee S.R. Hong E.-J. Sex hormone-binding globulin impedes hepatocellular carcinoma growth via MERTK regulation Genes Dis. 2021 in press 10.1016/j.gendis.2021.10.003 

  29. 29. Lee S. Lee J. Heo J. Jo S. Ryu J. Kim G. Yon J.-M. Lee M. Lee G.-S. An B.-S. Loss of PGRMC1 Delays the Progression of Hepatocellular Carcinoma via Suppression of Pro-Inflammatory Immune Responses Cancers 2021 13 2438 10.3390/cancers13102438 34069911 

  30. 30. Lee S.Y. Ju M.K. Jeon H.M. Jeong E.K. Lee Y.J. Kim C.H. Park H.G. Han S.I. Kang H.S. Regulation of Tumor Progression by Programmed Necrosis Oxidative Med. Cell. Longev. 2018 2018 3537471 10.1155/2018/3537471 

  31. 31. Knudsen A.R. Andersen K.J. Hamilton-Dutoit S. Nyengaard J.R. Mortensen F.V. Correlation between liver cell necrosis and circulating alanine aminotransferase after ischaemia/reperfusion injuries in the rat liver Int. J. Exp. Pathol. 2016 97 133 138 10.1111/iep.12188 27292534 

  32. 32. Scaffidi P. Misteli T. Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 2002 418 191 195 10.1038/nature00858 12110890 

  33. 33. Duarte S. Baber J. Fujii T. Coito A.J. Matrix metalloproteinases in liver injury, repair and fibrosis Matrix Biol. 2015 44 147 156 10.1016/j.matbio.2015.01.004 25599939 

  34. 34. Ma H.-P. Chang H.-L. Bamodu O.A. Yadav V.K. Huang T.-Y. Wu A.T.H. Yeh C.-T. Tsai S.-H. Lee W.-H. Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis Cancers 2019 11 786 10.3390/cancers11060786 

  35. 35. Rachfal A.W. Brigstock D.R. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis Hepatol. Res. 2003 26 1 9 10.1016/S1386-6346(03)00115-3 12787797 

  36. 36. Saile B. Matthes N. Knittel T. Ramadori G. Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells Hepatology 1999 30 196 202 10.1002/hep.510300144 10385656 

  37. 37. Carpino G. Morini S. Corradini S.G. Franchitto A. Merli M. Siciliano M. Gentili F. Muda A.O. Berloco P. Rossi M. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation Dig. Liver Dis. 2005 37 349 356 10.1016/j.dld.2004.11.009 15843085 

  38. 38. Fink S.L. Cookson B.T. Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells Infect. Immun. 2005 73 1907 1916 10.1128/IAI.73.4.1907-1916.2005 15784530 

  39. 39. Campbell K.J. Tait S.W.G. Targeting BCL-2 regulated apoptosis in cancer Open Biol. 2018 8 180002 10.1098/rsob.180002 29769323 

  40. 40. Ringelhan M. McKeating J. Protzer U. Viral hepatitis and liver cancer Philos. Trans. R. Soc. B Biol. Sci. 2017 372 20160274 10.1098/rstb.2016.0274 

  41. 41. Yu L.-X. Ling Y. Wang H.-Y. Role of nonresolving inflammation in hepatocellular carcinoma development and progression NPJ Precis. Oncol. 2018 2 1 10 10.1038/s41698-018-0048-z 29872720 

  42. 42. Bishayee A. The role of inflammation and liver cancer Adv. Exp. Med. Biol. 2014 816 401 435 24818732 

  43. 43. Jurikova M. Danihel L. Polak ?. Varga I. Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer Acta Histochem. 2016 118 544 552 10.1016/j.acthis.2016.05.002 27246286 

  44. 44. Brown J.R. Nigh E. Lee R.J. Ye H. Thompson M.A. Saudou F. Pestell R.G. Greenberg M.E. Fos Family Members Induce Cell Cycle Entry by Activating Cyclin D1 Mol. Cell. Biol. 1998 18 5609 5619 10.1128/MCB.18.9.5609 9710644 

  45. 45. Scholzen T. Gerdes J. The Ki-67 protein: From the known and the unknown J. Cell Physiol. 2000 182 311 322 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 10653597 

  46. 46. Tian Y. Wan H. Tan G. Cell cycle-related kinase in carcinogenesis Oncol. Lett. 2012 4 601 606 10.3892/ol.2012.828 23205069 

  47. 47. Wisdom R. Johnson R.S. Moore C. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms EMBO J. 1999 18 188 197 10.1093/emboj/18.1.188 9878062 

  48. 48. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation Cold Spring Harb. Perspect. Biol. 2009 1 a001651 10.1101/cshperspect.a001651 20457564 

  49. 49. Tan Q. Hu J. Yu X. Guan W. Lu H. Yu Y. Yu Y. Zang G. Tang Z. The Role of IL-1 Family Members and Kupffer Cells in Liver Regeneration BioMed Res. Int. 2016 2016 6495793 10.1155/2016/6495793 27092311 

  50. 50. Hammond G. Langley M.S. Robinson P.A. Nummi S. Lund L. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel Fertil. Steril. 1984 42 44 51 10.1016/S0015-0282(16)47956-2 6233179 

  51. 51. Mashchak C. Lobo R.A. Dozono-Takano R. Eggena P. Nakamura R.M. Brenner P.F. Mishell D.R. Comparison of pharmacodynamic properties of various estrogen formulations Am. J. Obstet. Gynecol. 1982 144 511 518 10.1016/0002-9378(82)90218-6 6291391 

  52. 52. Laurent M.R. Helsen C. Antonio L. Schollaert D. Joniau S. Vos M.J. Decallonne B. Hammond G. Vanderschueren D. Claessens F. Effects of sex hormone-binding globulin (SHBG) on androgen bioactivity in vitro Mol. Cell. Endocrinol. 2016 437 280 291 10.1016/j.mce.2016.08.041 27576188 

  53. 53. Davison S.L. Bell R. Donath S. Montalto J.G. Davis S.R. Androgen Levels in Adult Females: Changes with Age, Menopause, and Oophorectomy J. Clin. Endocrinol. Metab. 2005 90 3847 3853 10.1210/jc.2005-0212 15827095 

  54. 54. Hong H. Branham W.S. Ng H.W. Moland C.L. Dial S.L. Fang H. Perkins R. Sheehan D. Tong W. Human Sex Hormone-Binding Globulin Binding Affinities of 125 Structurally Diverse Chemicals and Comparison with Their Binding to Androgen Receptor, Estrogen Receptor, and α-Fetoprotein Toxicol. Sci. 2014 143 333 348 10.1093/toxsci/kfu231 25349334 

  55. 55. Onishi T. Shibahara T. Masui S. Sugino Y. Higashi S. Sasaki T. Efficacy of Ethinylestradiol Re-challenge for Metastatic Castration-resistant Prostate Cancer Anticancer Res. 2016 36 2999 3004 27272817 

  56. 56. Janne M. Deol H.K. Power S.G. Yee S.P. Hammond G.L. Human sex hormone-binding globulin gene expression in transgenic mice Mol. Endocrinol. 1998 12 123 136 9440816 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로